Lucio Claudio Rovati

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Postoperative Pain

Minimally Invasive

Intimate Partner Violence

Top Venues

British journal of pharmacology

Rottapharm Biotech

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rottapharm Biotech

Italy

Chief, Executive Officer

Publications

Emanuele Sala, Flora Ferrari, Marco Lanza, Chiara Milia, Chiara Sabatini, Albino Bonazzi, Eleonora Comi, Miriam Borsi Franchini, Gianfranco Caselli, Lucio Claudio Rovati
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models. British journal of pharmacology 177 (14) (2020)
Vittorio Vellani, Chiara Sabatini, Chiara Milia, Gianfranco Caselli, Marco Lanza, Ornella Letari, Lucio Claudio Rovati, Chiara Giacomoni
CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons. British journal of pharmacology 177 (1) (2019)